| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |